Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2020

May 15, 2020

SELL
$21.5 - $54.2 $109,650 - $276,420
-5,100 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$34.54 - $44.87 $6,908 - $8,974
200 Added 4.08%
5,100 $209,000
Q3 2019

Nov 14, 2019

BUY
$31.84 - $50.88 $156,016 - $249,312
4,900 New
4,900 $174,000

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $329M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.